SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
NexBio, Inc.’s DAS181 (Fludase(R)*) Improved Symptoms in a Severely Immunocompromised Patient with Parainfluenza Pneumonitis